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Abstract: For several years there is no conclusive guideline on the effectiveness of pulsatile or non-pulsatile perfu-
sion during cardiopulmonary bypass (CPB) in patients undergoing cardiac surgeries. In this study, we evaluated 
the effect of pulsatile versus continuous perfusion on the myocardial release of the cardiac biochemical markers 
including, creatine phosphokinase (CPK), cardiac creatine kinase (CK-MB), and lactate dehydrogenase (LDH), and 
also kidney function tests including: blood urea nitrogen test (BUN) and creatinine test (Cr) in patients that under-
went both pulsatile and non-pulsatile methods before and after heart surgeries. A total of 80 patients were enrolled 
in this study, 40 patients in each pulsatile and non-pulsatile group. Venous blood samples were drown from each 
patient in two groups before operation and after operation at, 24, 48, and 72 h and analyzed separately for CPK, 
its cardiac isoenzyme (CK-MB), LDH, BUN and Cr. There were no significant differences between the two groups 
with regard to preoperative parameters such as sex, age, and body surface area. Our study shows that the effect of 
pulsatile perfusion on cardiac and kidney function is better than the non-pulsatile method.
Keywords: Cardiopulmonary bypass, pulsatile, non-pulsatile, biochemical markers, kidney function
Introduction
Cardiopulmonary Bypass (CPB), during open-
heart surgeries facilitates cardiac manipulation 
and helps maintenance of hemodynamic stabil-
ity [1]. CPB causes increased vascular permea-
bility, release of oxygen free radicals and lyso-
somal enzymes from white blood cells, and 
endothelial damage. Even though non-pulsatile 
or continuous cardiopulmonary bypass (CPB) is 
used more widely than pulsatile CPB, it enhanc-
es transient dysfunction of the pulmonary sys-
tem [2]. Pulsatile CPB is considered to be more 
natural and beneficial than continuous perfu-
sion, because pulsatile flow provides motion of 
the tissue fluid around cell membrane, improves 
microcirculation and increases diffusion. It also 
facilitates decreased systemic vascular resis-
tance and enhanced oxygen consumption [3].
Despite accepted theoretical concepts, pulsa-
tile CPB has not been widely used; the reason 
is lacking objective data on the effectiveness of 
this method. This study aims to explore advan-
tages or beneficial effects of pulsatile versus 
continuous perfusion during CPB in patients 
undergoing cardiac surgeries. In this study, in 
order to evaluate the effect of pulsatile versus 
continuous perfusion, the myocardial release of 
the important cardiac biochemical markers 
were examined, these factors are common 
markers of the myocardial stable state [4, 5]. 
These biochemical markers include, creatine 
phosphokinase (CPK), cardiac creatine kinase 
(CK-MB), and lactate dehydrogenase (LDH), and 
also kidney functional tests including: blood 
urea nitrogen test (BUN) and creatinine test (Cr) 
in patients that underwent both pulsatile and 
non-pulsatile methods before and after heart 
surgeries were examined.
Patients and methods
This randomized controlled trial was carried out 
at Imam Khomeini Hospital, Ardabil, Iran. An 
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ethics committee of Human Research of Ardabil 
University of Medical Sciences approved the 
study. Measurement of biochemical markers 
and kidney function after cardiovascular sur-
geries is routine and all patients gave an 
informed consent before enrolment.
Anesthesia
Anesthetic technique was standardized and 
performed according to a standard protocol [6].
All patients underwent central venous pressure 
(CVP) through the right internal jugular vein for 
continuous hemodynamic monitoring before 
anesthetic induction.
Postoperative chest roentgenogram approved 
its exact positioning. Anesthetic technique was 
the same for all patients: induc-
tion of anesthesia consisted of 
intravenous propofol infusion at 3 
mg/kg combined with fentanyl 
administration at 0.1 mg/kg. 
Neuromuscular blockade was 
achieved by 4 mg/hour pancuroni-
um bromide, and lungs were venti-
lated to normocapnia with air and 
oxygen (45% to 50%). A positive 
end-expiratory pressure (PEEP) 
was set at 5 mm Hg. 
Application of cardiopulmonary 
bypass perfusion was performed 
using Stöckert S5 roller pump.
Blood sampling and biochemical 
markers
Venous blood samples were drown 
from each patient in two groups 
before operation and postopera-
tively at, 24, 48, and 72 h and ana-
lyzed separately for CPK, its cardi-
ac isoenzyme (CK-MB), LDH, BUN 
and Cr.
All samples were immediately cen-
trifuged for 10 min at 3000 g (rcf), 
and serum enzyme activities were 
measured at 37°C. Serum BUN, 
Cr, CPK, CK-MB, and LDH determi-
nations were done by means of 
test kits (Pars Azmoon, Iran) using 
an auto-analyzer system (BT 
3000, Italy). 
Table 1. Demographics and characteristics
Pulsatile Non-pulsatile
Gender (male/female) 20/20 21/19
Age (years old) 61.4 ± 12.3 60.1 ± 8.7
Height (cm) 167.1 ± 9.7 165.3 ± 8.7
Weight (kg) 75.2 ± 11.9 73.8 ± 15.6
Body Surface (m2) 1.884 ± 0.255 1.826 ± 0.209
Figure 1. Creatine phosphokinase (CPK) concentration in pulsatile and 
non-pulsatile groups, 24 h, 48 h, and 72 h after operation.
Statistical analysis
Statistical analysis was performed using a 
graph and data analysis software package 
(SigmaPlot 12.0, Systat Software, Inc.). Data 
are presented as mean ± SD, except in figures 
where error bars represent SEM. ANOVA tests 
followed by the pairwise Student-Newman-
Keuls test for multiple comparisons were per-
formed to check for differences. P value less 
than 0.05 was considered significant.
Results
There was no recorded case of mortality or 
morbidity in the two groups of patients. There 
were no significant differences between the 
two groups with regard to preoperative param-
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eters such as sex, age, and body 
surface area. Cumulative cardiac 
biochemical markers and kidney 
function release were calculated 
as the mean net release before 
operation and at all 3 measuring 
time points after operation.
Baseline characteristics of the 
two groups are summarized in 
Table 1. Both kidney function 
tests showed that the BUN and Cr 
were dysregulated more in non-
pulsatile group in comparison to 
the pulsatile group.
Serum concentrations of CPK 
decreased at 24 h (p = 0.03). but 
increased afterward and reached 
a peak level at 72 h after opera-
tion in both groups; but these 
increase were much higher in the 
non-pulsatile group (Figure 1, p ≤ 
0.001). 
Levels of CK-MB postoperatively 
were markedly greater in the non-
pulsatile at 48 h and 72 h, in con-
trast, its levels were decreased in 
the same time points in pulsatile 
group (Figure 2, P ≤ 0.001).
Serum levels of LDH were 
increased in both groups postop-
eratively, but its levels were 
increased significantly in non-pul-
satile patients (Figure 3, p ≤ 
0.001). 
In addition, same with myocardial 
injury markers, kidney function 
markers, were also dys-regulated 
much more in non-pulsatile group 
than the pulsatile group. Blood Cr 
was increased at 48 and 72 hours 
more considerably in non-pulsatile 
than in pulsatile group (Figure 4). 
Additionally, blood BUN values 
were decreased in pulsatile 
patients at 24 h (p ≤ 0.001), also 
at 48 h and 72 h (p = 0.01), (Figure 
5). However, in non- pulsatile 
patients, BUN was diminished at 
24 h (p = 0.01), but it were 
increased at 48 h and 72 h (p ≤ 
0.001).
Figure 2. Cardiac creatine kinase (CK-MB) concentration in pulsatile 
and non-pulsatile groups, 24 h, 48 h, and 72 h after operation.
Figure 3. Lactate dehydrogenase (LDH) concentration in pulsatile and 
non-pulsatile groups, 24 h, 48 h, and 72 h after operation.
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Discussion
The literature suggests that pulsa-
tile flow should be routinely used 
during CPB in moderate- to high-
risk open heart surgery. In recent 
years, increasing evidence sup-
ports a shift toward pulsatility in 
open heart cardiac surgeries over 
non-pulsatility [7]. Clinical evi-
dences show better cardiac, renal, 
and pulmonary outcomes in 
patients receiving pulsatile perfu-
sion [8-10]. The beneficial impact 
of pulsatile flow include reducing 
the systemic inflammatory res-
ponse syndrome associated with 
bypass, decreased need for ino- 
tropic support, shortened hospital 
stay, and superior organ preserva-
tion [9, 11, 12]. Additionally, it has 
been found that the use of pulsa-
tile flow during and after pediatric 
open heart surgery resulted in 
improved patient outcomes in 
terms of preserving better cardiac, 
renal, and pulmonary functions in 
the early post-CPB period [13]. 
There is a continuing debate about 
the physiologic impact of non-pul-
satile perfusion. Possible reasons 
for inconsistency and ongoing con-
troversy could be the difference in 
the hemodynamic energy levels 
produced by specific pulsatile and 
nonpulsatile pumps, using improp-
er patient-selection criteria, inap-
propriate manipulation of pulsatile 
flow during CPB, and choosing 
unsuitable extracorporeal-circuit 
components [14].
However, our results are consis-
tent with other findings that dem-
onstrate the effectiveness of the 
pulsatile perfusion. Myocardial 
injury markers showed that chang-
es in non-pulsatile method were 
more significant. Surprisingly, 
CPK-MB levels were decreased in 
pulsatile group at 48 h and 72 h 
after operation, on the contrary, 
its levels in non-pulsatile group 
were drastically increased at the 
Figure 4. Creatinine (Cr) concentration in pulsatile and non-pulsatile 
groups, 24 h, 48 h, and 72 h after operation.
Figure 5. Blood urea nitrogen test (BUN) concentration in pulsatile and 
non-pulsatile groups, 24 h, 48 h, and 72 h after operation.
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same time points (Figure 2). Furthermore, 
results for CPK and LDH have the same mean-
ing. CPK and LDH values were markedly 
increased in non-pulsatile group than the pul-
satile group (Figures 1 and 3). 
On the other side, kidney function markers 
showed consistent results with cardiac bio-
chemical markers. Cr levels were increased 
more significantly in non-pulsatile group at 48 h 
and 72 h postoperatively than the pulsatile 
group (Figure 4) In addition, BUN levels were 
decreased in pulsatile patients at three time 
points especially after 24 h; but in non-pulsatile 
patients its levels decreased at 24 h and incre- 
ased 48 h and 72 h after operation (Figure 5).
All in all, our study shows that the effect of pul-
satile perfusion on cardiac and kidney function 
is better than the non-pulsatile method. It 
would be beneficial if other studies evaluate 
other of circuit components and patient out-
comes. Nonetheless, it has to be mention that 
other large-scale clinical trials would be much 
more confirmative. 
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